Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolution of structural rearrangements in prostate cancer intracranial metastases. | NPJ Precis Oncol | 2023 | 37704749 | PubTator, text mining | PubMed |
| The current landscape of m6A modification in urological cancers. | PeerJ | 2023 | 37701836 | PubTator, text mining | PubMed |
| YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation. | Cancer Sci | 2023 | 37700438 | PubTator, text mining | PubMed |
| Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. | Cancer Discov | 2023 | 37694973 | PubTator, text mining | PubMed |
| Rare Manifestation of Pancreaticobiliary Cancer With Extrahepatic Lesions. | Cureus | 2023 | 37692734 | PubTator, text mining | PubMed |
| Pre-Clinical Models to Study Human Prostate Cancer. | Cancers (Basel) | 2023 | 37686488 | PubTator, text mining | PubMed |
| Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs. | Int J Mol Sci | 2023 | 37686423 | PubTator, text mining | PubMed |
| Knockout of the Cardiac Transcription Factor NKX2-5 Results in Stem Cell-Derived Cardiac Cells with Typical Purkinje Cell-like Signal Transduction and Extracellular Matrix Formation. | Int J Mol Sci | 2023 | 37686171 | PubTator, text mining | PubMed |
| Notch and retinoic acid signals regulate macrophage formation from endocardium downstream of Nkx2-5. | Nat Commun | 2023 | 37669937 | PubTator, text mining | PubMed |
| Case Report: Tumor-to-tumor metastasis with prostate cancer metastatic to lung cancer: the first reported case. | Front Oncol | 2023 | 37664049 | PubTator, text mining | PubMed |
| Massive mixed epithelial-stromal tumour of seminal vesicle requiring challenging abdominoperineal resection: a case report and review of literature. | J Surg Case Rep | 2023 | 37662445 | PubTator, text mining | PubMed |
| Analysis of adverse drug reactions/events of cancer chemotherapy and the potential mechanism of Danggui Buxue decoction against bone marrow suppression induced by chemotherapy. | Front Pharmacol | 2023 | 37654610 | PubTator, text mining | PubMed |
| A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang. | Pharmgenomics Pers Med | 2023 | 37641720 | PubTator, text mining | PubMed |
| Stroke-Induced Central Pain: Overview of the Mechanisms, Management, and Emerging Targets of Central Post-Stroke Pain. | Pharmaceuticals (Basel) | 2023 | 37631018 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects. | Molecules | 2023 | 37630387 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study. | Biomedicines | 2023 | 37626805 | PubTator, text mining | PubMed |
| Metastatic Lung Adenocarcinoma: A Case of Unusual Presentation With a Skull Mass. | Cureus | 2023 | 37621819 | PubTator, text mining | PubMed |
| Increased Bone Formation and Accelerated Bone Mass Accrual in a Man Presenting with Diffuse Osteosclerosis/High Bone Mass Phenotype and Adenocarcinoma of Unknown Primary. | JBMR Plus | 2023 | 37614304 | PubTator, text mining | PubMed |
| A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. | Nat Commun | 2023 | 37612286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=14